Here, the authors develop a deep-learning algorithm to predict biomarkers from histopathological imaging in advanced urothelial cancer patients. This method detects suitable patients for targeted therapy clinical trials with a significant reduction in molecular testing, providing cost and time savings in real-world clinical settings.
- Albert Juan Ramon
- Chaitanya Parmar
- Kristopher A. Standish
